Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis-Reference-Cited by-同舟云学术

Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis

Published:2017-12 Issue:6 Volume:75 Page:511-520
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Abad Raquel^ORCID,Medina Verónica,Fariñas Maria del Carmen,Martínez-Martínez Luis,Bambini Stefania,Dari A.,Medini Duccio,Pizza Mariagrazia,Vázquez Julio A.

Funder

Fondo de Investigacion Sanitario from Spain

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference39 articles.

1. Global epidemiology of invasive meningococcal disease;Jafri;Popul Health Metr,2013

2. Meningococcal carriage and disease – population biology and evolution;Caugant;Vaccine,2009

3. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway;Yazdankhah;J Clin Microbiol,2004

4. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers;Caugant;Infect Immun,1988

5. Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica;Kremastinou;FEMS Immunol Med Microbiol,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular typing of group B Neisseria meningitidis’subcapsular antigens directly on biological samples demonstrates epidemiological congruence between culture-positive and -negative cases: A surveillance study of invasive disease over a 13-year period;Journal of Infection;2021-04

2. Neisseria meningitidis and meningococcal disease;Current Opinion in Infectious Diseases;2019-12

3. Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation;PLOS ONE;2018-12-28

4. Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines;Human Vaccines & Immunotherapeutics;2018-04-30